Growth factors and pathogenesis

Best Pract Res Clin Obstet Gynaecol. 2016 Jul:34:25-36. doi: 10.1016/j.bpobgyn.2015.08.018. Epub 2015 Sep 25.

Abstract

Growth factors are relatively small and stable, secreted or membrane-bound polypeptide ligands, which play an important role in proliferation, differentiation, angiogenesis, survival, inflammation, and tissue repair, or fibrosis. They exert multiple effects through the activation of signal transduction pathways by binding to their receptors on the surface of target cells. A number of studies have demonstrated the central role of growth factors and their signaling pathways in the pathogenesis of uterine leiomyomas. Numerous differentially expressed growth factors have been identified in leiomyoma and myometrial cells. These growth factors can activate multiple signaling pathways (Smad 2/3, ERK 1/2, PI3K, and β-catenin) and regulate major cellular processes, including inflammation, proliferation, angiogenesis, and fibrosis which are linked to uterine leiomyoma development and growth. In this chapter, we discuss the role of growth factors and their signaling pathways in the pathogenesis of uterine leiomyomas.

Keywords: TGF-β; VEGF; activin-A; growth factors; uterine fibroid; uterine leiomyoma.

MeSH terms

  • Animals
  • Female
  • Humans
  • Intercellular Signaling Peptides and Proteins / metabolism*
  • Leiomyoma / drug therapy
  • Leiomyoma / etiology
  • Leiomyoma / metabolism*
  • Leiomyoma / pathology
  • Molecular Targeted Therapy*
  • Signal Transduction*
  • Uterine Neoplasms / drug therapy
  • Uterine Neoplasms / etiology
  • Uterine Neoplasms / metabolism*
  • Uterine Neoplasms / pathology

Substances

  • Intercellular Signaling Peptides and Proteins